Filing Details

Accession Number:
0001209191-15-028872
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-24 17:14:52
Reporting Period:
2015-03-20
Filing Date:
2015-03-24
Accepted Time:
2015-03-24 17:14:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557421 Ignyta Inc. RXDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283290 E Jonathan Lim C/O Ignyta, Inc.
11095 Flintkote Avenue, Suite D
San Diego CA 92121
President, Ceo & Director Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-20 20,000 $9.01 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,316,668 Indirect By City Hill Venture Partners I, LLC
Footnotes
  1. Reflects the weighted average sale price of the shares purchased. 1,700 shares were purchased at $9.0076 per share and 18,300 shares were purchased at $9.0095 per share.
  2. The Reporting Person is the Manager of City Hill Ventures, LLC, which is the Manager of City Hill Ventures Partners I, LLC, and as such the Reporting Person and City Hill Ventures, LLC have the power to vote or dispose of the securities held of record by the Reporting Person and may be deemed to beneficially own those securities. The Reporting Person disclaims beneficial ownership of the securities held of record by the City Hill Venture Partners I, LLC except to the extent of his pecuniary interest therein.